The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

212 reports and counting

Updated daily with latest market intelligence
Fundraising
Tune Therapeutics

Tune Therapeutics Raises $175M in Growth

Tune Therapeutics, a HealthTech company based in Durham, NC, has raised $175M in Growth led by Hevolution, New Enterprise Associates.

Fundraising News Team
Aug 8, 2025
0 min read
HealthTech
Tune Therapeutics

Tune Therapeutics raises $175M Growth

Tune Therapeutics raises $175M in Growth. Epigenetic programming startup developing therapies for chronic conditions...

Editorial Team
Aug 8, 2025
0 min readβ€’$175M
Biotech
Tune Therapeutics

Tune Therapeutics raises $175M Series B at $900M valuation

Tune Therapeutics raises $175M in Series B at $900M valuation. Epigenetic gene regulation therapies...

Editorial Team
Feb 12, 2025
0 min readβ€’$175M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min readβ€’$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min readβ€’$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min readβ€’$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min readβ€’$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min readβ€’$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min readβ€’$400M
Page 1

Showing 9 reports β€’ Page 1 β€’ Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.